Obesity Affects PKs of Newer Beta-Lactam Combinations

New abstracts from investigators presented at MAD-ID 2025 provide more evidence of two-drug antibiotic combinations ...

JUNE 2, 2025

Better Tools for Fighting Gram-Negative Infections, but More Are Needed

Multidrug-resistant gram-negative bacteria are difficult to treat, but FDA approvals have increased the clinical ...

FEBRUARY 27, 2025

Looking at 2 Antimicrobials for Drug-Resistant Pseudomonas aeruginosa

The purpose of this review is to discuss the in vitro activity and real-world evidence of ceftolozane-tazobactam ...

FEBRUARY 26, 2025

CACTUS Study: CZA and C/T Similarly Effective Against Resistant Pseudomonas

Researchers saw clinical success with both ceftazidime-avibactam and ceftolozane-tazobactam MDR Pseudomonas ...

OCTOBER 13, 2023

Early Avycaz Therapy Increases Success Rates for MDR P. aeruginosa Pneumonia

Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa is a prevalent and ...

AUGUST 28, 2023

Something to Cry About: Pseudomonas aeruginosa Linked to Artificial Tears

The CDC reported an outbreak of Pseudomonas aeruginosa linked to artificial tear products in 12 states, so far.

FEBRUARY 3, 2023

Avycaz, a Viable Alternative to Zerbaxa for P. aeruginosa Infections

Ceftazidime-avibactam (C/A; Avycaz, Allergan) may be a viable, effective treatment alternative to ...

DECEMBER 5, 2022

Efficacy of Antibiotics in CF Patients May Be Affected by pH, Oxygen in Lungs

Changing the pH environment in the lungs might help CF patients battle chronic lung infections.

OCTOBER 19, 2018

IMI/REL Shows Promise Against Drug-Resistant Infections

Merck's investigational combination relebactam-imipenem may fill a critical void in therapies effective against ...

SEPTEMBER 11, 2018

FDA Clears T2Bacteria Panel for Detecting Sepsis-Causing Pathogens

Sepsis affects 1.6 million U.S. patients each year, resulting in more than 250,000 deaths.

JUNE 2, 2018